On October 23, 2017, FDA announced the release of new educational materials to help health care professionals understand what biosimilars are and how they are approved. The materials include four fact sheets and graphics that provide definitions for relevant terminology, describe the biosimilar approval process, and explain the benefits of biosimilars. FDA also created social media posts for external stakeholders to use and share on their own social media channels. The FDA website contains additional biosimilars resources, such as online courses, webinars, and presentations.
The post FDA Releases Biosimilars Educational Materials appeared first on Goodwin Procter BioSimilars Blog.